Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 4;12(17):10374-10378.
doi: 10.1039/d2ra01332k. eCollection 2022 Mar 31.

Coupling nucleic acid circuitry with the CRISPR-Cas12a system for universal and signal-on detection

Affiliations

Coupling nucleic acid circuitry with the CRISPR-Cas12a system for universal and signal-on detection

Rujian Zhao et al. RSC Adv. .

Abstract

We report a universal and signal-on HCR based detection platform via innovatively coupling the CRISPR-Cas12a system with HCR. By using this CRISPR-HCR pathway, we can detect different targets by only changing the crRNA. The CRISPR-HCR platform coupling with an upstream amplifier can achieve a practical sensitivity as low as ∼aM of ASFV gene in serum.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

Figures

Scheme 1
Scheme 1. Schematic illustration of the CRISPR-HCR platform. (a) Principle of CRISPR-Cas12a-mediated cis and trans cleavage of DNA. (b and c) CRISPR-HCR platform. Without the target sequence, I0 activates the HCR assembly and produces low fluorescence background due to FRET (b). After target binds with crRNA, Cas12a cleaves I0 and remains HCR unreacted, producing increased fluorescence targeting signal (c).
Fig. 1
Fig. 1. Performance verification for CRISPR-HCR platform. (a) Signal (fluorescence spectra) comparison between traditional HCR and CRISPR-HCR strategy. (b) 3D-Barograph for the optimization of the signal-to-background ratio of CRISPR-HCR. (c) Barograph of the fluorescence intensity to validate the universality of the CRISPR-HCR with different targets, including dsDNA-T1 (blue), dsDNA-T2 (orange) and ssDNA-T (purple), the real-time fluorescence signal has been shown in Fig. S2. The error bars represent standard deviation from two independent tests.
Fig. 2
Fig. 2. Coupling LAMP with CRISPR-HCR platform (LAMP-CRISPR-HCR). (a) Schematic illustration of CRISPR-HCR system coupling with LAMP reaction. (b) Fluorescence spectra of CRISPR-HCR for ASFV-LAMP-products amplified from different amounts of synthetic dsDNA-ASFV. (c) Fluorescence spectra of the CRISPR-HCR for LAMP products amplified from specific target (5000 copies per μL dsDNA-ASFV), and non-specific targets (water control “NC”, 20 000 copies per μL synthetic dsDNA-MERS and dsDNA-M13mp18). dsDNA-MERS and dsDNA-M13mp18 is, in respective, the synthetic DNA sequence segmented from MERS-CoV and M13mp18 gene. (d) Fluorescence spectra of CRISPR-HCR for ASFV-LAMP-products amplified from water control “NC” and different dilutions of the dsDNA-ASFV extracts in pig serum sample.
Fig. 3
Fig. 3. Verification of the flexibility via coupling CRISPR with CHA circuit (CRISPR-CHA). (a and b) Schematic illustration of CRISPR-CHA. Without the target sequence, C1 activates the CHA assembly and produces low fluorescence back-ground due to FRET (a). After target binds with crRNA, Cas12a cleaves C1 and remains CHA unreacted, producing increased fluorescence targeting signal (b). (c) Fluorescence kinetic curves of CRISPR-CHA without (“NC”) and with different concentrations of dsDNA-T1, in presence of C1, H3, H4-FAM and BlackQ1-P:cP. (d) Barograph of the fluorescence intensity of CRISPR-CHA detection for the ASFV-LAMP-products amplified from water control (“LAMP-CRSIPR-CHA NC”) and 500 copies per μL dsDNA-ASFV (“LAMP-CRSIPR-CHA PC”). The error bars represent standard deviation from two independent tests.

Similar articles

Cited by

References

    1. Li B. Ellington A. D. Chen X. Nucleic Acids Res. 2011;39:e110. doi: 10.1093/nar/gkr504. - DOI - PMC - PubMed
    1. Jung C. Ellington A. D. Acc. Chem. Res. 2014;47:1825–1835. doi: 10.1021/ar500059c. - DOI - PMC - PubMed
    1. Yin P. Choi H. M. T. Calvert C. R. Pierce N. A. Nature. 2008;451:318–322. doi: 10.1038/nature06451. - DOI - PubMed
    1. Chen X. Briggs N. McLain J. R. Ellington A. D. Proc. Natl. Acad. Sci. U. S. A. 2013;110:5386–5391. doi: 10.1073/pnas.1222807110. - DOI - PMC - PubMed
    1. Dirks R. M. Pierce N. A. Proc. Natl. Acad. Sci. U. S. A. 2004;101:15275–15278. doi: 10.1073/pnas.0407024101. - DOI - PMC - PubMed